Skip to main content
. 2022 Jan 11;11:761030. doi: 10.3389/fonc.2021.761030

Table 1.

Association between BGN expression and clinicopathological factors of colon cancer patients.

Variables Number of cases Up-regulation of Biglycan numbers (%) p value
Positive (N=84) Negative (N=60)
Gender
 Male 99 58(69.05%) 41(68.33%) 0.927
 Female 45 26(30.95%) 19(31.67%)
Age (years)
 >=60 89 53(63.10%) 36(60.00%) 0.706
 <60 55 31(36.90%) 24(40.00%)
Tumor location
 Colon 83 52(61.90%) 31(51.67%) 0.220
 Rectum 61 32(38.10%) 29(48.33%)
Tumor size
 T1/T2 28 11(13.10%) 17(28.33%) 0.023
 T3/T4 116 73(86.90%) 43(71.67%)
Lymph node metastasis
 N0 68 41(48.81%) 27(45.00%) 0.652
 N1/N2 76 43(51.19%) 33(55.00%)
Distant metastasis
 M0 112 62(73.81%) 50(83.33%) 0.175
 M1 32 22(26.19%) 10(16.67%)
length of hospitalization
 < 10 days 44 20(23.81%) 24(40.00%) 0.038
 <=10 days 100 64(76.19%) 36(60.00%)
Tumor type
 ulcerative 33 18(21.43%) 15(25.00%) 0.615
 Non-ulcerative 111 66(78.57%) 45(75.00%)
Tumor differentiation
 Well to moderate 128 76(92.68%) 52(89.66%) 0.528
 Poor 12 6(7.32%) 6(10.34%)
Tumor stage
 I 19 8(9.52%) 11(18.33%) 0.124
 II/III/IV 125 76(90.48%) 49(81.67%)
Disease duration
 >3 months 45 28(33.73%) 17(29.31%) 0.580
 <=3 months 96 55(66.27%) 41(70.69%)
Serosa invasion
 Yes 115 73(86.90%) 42(70.00%) 0.002
 No 29 11(13.10%) 18(30.00%)

Length of stay was defined as the number of days the patient was hospitalized for surgical treatment of colon cancer. One day was defined as a hospital stay crossing midnight and was determined by independent physician review from medical records and patient reports. The p value was calculated by the Chi-square test. Bold numbers indicate statistically significant values (p < 0.05).